Whalesbook
Jubilant Pharmova has issued a critical reminder to shareholders concerning unclaimed dividends and associated shares from the financial year 2018-19. The company is urging shareholders who have not yet claimed these entitlements to take action by May 15, 2026.
If dividends and shares from FY 2018-19 remain unclaimed after this date, they will be transferred to the Investor Education and Protection Fund (IEPF) by October 31, 2026. This applies to all unpaid dividends, including instances involving specific unclaimed equity shares, such as 445 shares noted in one particular folio.
Why Shareholders Must Act
This notification is vital for shareholders who may have overlooked past dividend payments or share holdings. Failing to claim these assets by the May 15, 2026 deadline means they will be transferred to the IEPF, a government fund. Recovering assets from the IEPF can be a complex and lengthy process.
Regulatory Requirements
Under Indian law, specifically Section 124 of the Companies Act, 2013, dividends that remain unpaid for seven consecutive years must be transferred to the IEPF. This rule also extends to the equity shares linked to these unclaimed dividends. Jubilant Pharmova has previously followed similar procedures for earlier financial years. The IEPF Authority typically offers a window for claims for up to 25 years post-transfer.
Action Needed: Claim Your Assets
Shareholders entitled to unclaimed dividends from FY 2018-19 must contact Alankit Assignments Limited to submit their claim. The deadline for submission is May 15, 2026. This notice also covers shareholders holding old, unexchanged share certificates from erstwhile entities, who should verify their status and follow the necessary steps.
The Risk of Inaction
The primary risk is for shareholders who are unaware of this notification or who miss the May 15, 2026 deadline. They stand to lose their unclaimed dividends and associated shares. While it's possible to claim from the IEPF later, it involves additional procedures and potential complications.
Industry Standards
Companies in the pharmaceutical sector, including peers like Sun Pharma, Divi's Laboratories, and Zydus Lifesciences, operate under strict regulatory frameworks. Adherence to SEBI and Ministry of Corporate Affairs (MCA) guidelines, such as those concerning shareholder communications and the transfer of unclaimed assets to the IEPF, is a standard industry obligation.
Key Dates to Remember
- May 15, 2026: Deadline for shareholders to claim unpaid FY19 dividends and shares.
- October 31, 2026: Date for the transfer of all remaining unclaimed FY19 dividends and shares to the IEPF.
Next Steps
Investors will want to monitor the number of claims successfully processed by Alankit Assignments Limited. The company is set to complete the transfer to the IEPF for any remaining unclaimed assets on October 31, 2026.